Form D · Pharmaceuticals
Spectrix Therapeutics, LLC
Southlake, TX · CIK 0001675383
Offering snapshot reported Jun 3, 2016 · SEC filing
- Reported sold
- $249K Offering amount: $249K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 20, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 3, 2016 | Initial | $249,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-264350
Source: Form D, filed Jun 3, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Tengler | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2535 East Southlake Boulevard Suite 200
Southlake, TX, 76092
Southlake, TX, 76092